RKDA
Arcadia Biosciences, Inc.
Price Chart
Latest Quote
$0.84
-0.01 (-1.73%)
Current Price
| Previous Close | $0.85 |
| Open | $0.85 |
| Day High | $0.85 |
| Day Low | $0.79 |
| Volume | 72,728 |
Stock Information
| Shares Outstanding | 2.06M |
| Cash Equivalents | $3.72M |
| Revenue | $4.76M |
| Net Income | $-9.32M |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Market Cap | $1.60M |
| EPS (TTM) | $-5.50 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-2.12M |
| Sales | $4.76M |
| Income | $-9.32M |
| Book/sh | $1.40 |
| Cash/sh | $1.81 |
| Employees | 8 |
Financial Ratios
| Quick Ratio | 3.04 |
| Current Ratio | 3.79 |
Returns & Margins
| ROA | -32.83% |
| ROE | -158.15% |
| Gross Margin | 34.32% |
| Operating Margin | -70.82% |
| Profit Margin | -195.94% |
Ownership
| Insider Ownership | 0.55% |
| Institutional Ownership | 16.99% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.61 |
| P/S | 0.34 |
| P/B | 0.55 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.94 |
| SMA50 | $1.05 |
| SMA200 | $2.42 |
| RSI | 38.94 |
| ATR | 0.1857 |
| Shares Float | 1.77M |
| Short Float | 20.02% |
| Short Ratio | 0.14 |
| Volatility | 0.50 |
| Rel Volume | 0.01 |
Performance History
| Week | -27.38% |
| Month | -15.45% |
| Quarter | -52.91% |
| 6 Months | -78.65% |
| YTD | -63.86% |
| Year | -84.40% |
| 3 Years | -82.54% |
| 5 Years | -99.34% |
| 10 Years | -99.96% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.78 | 84,400 |
| 2026-06-17 | $0.84 | 73,500 |
| 2026-06-16 | $0.85 | 288,700 |
| 2026-06-15 | $0.92 | 568,100 |
| 2026-06-12 | $1.03 | 2,616,100 |
| 2026-06-11 | $1.07 | 122,272,400 |
| 2026-06-10 | $0.90 | 20,100 |
| 2026-06-09 | $0.92 | 67,300 |
| 2026-06-08 | $0.93 | 54,600 |
| 2026-06-05 | $1.07 | 202,600 |
| 2026-06-04 | $1.03 | 134,100 |
| 2026-06-03 | $1.00 | 90,700 |
| 2026-06-02 | $1.01 | 407,000 |
| 2026-06-01 | $0.92 | 81,000 |
| 2026-05-29 | $0.96 | 135,000 |
| 2026-05-28 | $0.96 | 149,600 |
| 2026-05-27 | $0.93 | 133,500 |
| 2026-05-26 | $0.91 | 231,400 |
| 2026-05-22 | $0.92 | 633,000 |
| 2026-05-21 | $0.91 | 1,230,900 |
| 2026-05-20 | $0.95 | 59,747,900 |
| 2026-05-19 | $0.92 | 28,600 |
About Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $3,098,000 | $2,963,000 | $2,174,000 | $6,101,000 |
| Cost Of Revenue | $3,098,000 | $2,963,000 | $2,174,000 | $6,101,000 |
| Total Revenue | $4,858,000 | $5,045,000 | $4,454,000 | $7,418,000 |
| Operating Revenue | $4,858,000 | $5,045,000 | $4,454,000 | $7,418,000 |
| Expenses | ||||
| Total Expenses | $14,853,000 | $12,657,000 | $10,472,000 | $22,646,000 |
| Other Income Expense | $7,443,000 | $2,521,000 | $2,000 | $4,125,000 |
| Other Non Operating Income Expenses | $2,309,000 | $31,000 | $-382,000 | $-305,000 |
| Net Non Operating Interest Income Expense | $221,000 | $782,000 | $695,000 | $289,000 |
| Operating Expense | $11,755,000 | $9,694,000 | $8,298,000 | $16,545,000 |
| Total Other Finance Cost | - | - | - | $-289,000 |
| Interest Expense | - | - | - | - |
| Interest Expense Non Operating | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-2,339,000 | $-4,317,000 | $-5,324,000 | $-10,592,000 |
| Net Interest Income | $221,000 | $782,000 | $695,000 | $289,000 |
| Interest Income | $221,000 | $782,000 | $695,000 | $289,000 |
| Normalized Income | $-6,394,860 | $-6,284,100 | $-5,627,360 | $-15,017,570 |
| Net Income From Continuing And Discontinued Operation | $-2,339,000 | $-7,038,000 | $-13,981,000 | $-15,376,000 |
| Total Operating Income As Reported | $-2,500,000 | $-3,648,000 | $-6,102,000 | $-14,007,000 |
| Net Income Common Stockholders | $-2,339,000 | $-7,038,000 | $-13,981,000 | $-15,376,000 |
| Net Income | $-2,339,000 | $-7,038,000 | $-13,981,000 | $-15,376,000 |
| Net Income Including Noncontrolling Interests | $-2,339,000 | $-7,038,000 | $-13,986,000 | $-15,612,000 |
| Net Income Discontinuous Operations | $0 | $-2,721,000 | $-8,657,000 | $-4,784,000 |
| Net Income Continuous Operations | $-2,339,000 | $-4,317,000 | $-5,329,000 | $-10,828,000 |
| Pretax Income | $-2,331,000 | $-4,309,000 | $-5,321,000 | $-10,814,000 |
| Special Income Charges | $2,750,000 | $3,964,000 | $-84,000 | $1,221,000 |
| Interest Income Non Operating | $221,000 | $782,000 | $695,000 | $289,000 |
| Operating Income | $-9,995,000 | $-7,612,000 | $-6,018,000 | $-15,228,000 |
| Gross Profit | $1,760,000 | $2,082,000 | $2,280,000 | $1,317,000 |
| Per Share | ||||
| Diluted EPS | $-1.71 | $-5.17 | $-11.29 | $-25.65 |
| Basic EPS | $-1.71 | $-5.17 | $-11.29 | $-25.65 |
| Other | ||||
| Tax Effect Of Unusual Items | $1,078,140 | $522,900 | $80,640 | $4,430 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-15,097,000 | $-9,989,000 | $-6,115,000 | $-19,179,000 |
| Total Unusual Items | $5,134,000 | $2,490,000 | $384,000 | $4,430,000 |
| Total Unusual Items Excluding Goodwill | $5,134,000 | $2,490,000 | $384,000 | $4,430,000 |
| Reconciled Depreciation | $32,000 | $113,000 | $287,000 | $479,000 |
| EBITDA (Bullshit earnings) | $-9,963,000 | $-7,499,000 | $-5,731,000 | $-14,749,000 |
| EBIT | $-9,995,000 | $-7,612,000 | $-6,018,000 | $-15,228,000 |
| Diluted Average Shares | $1,368,057 | $1,363,303 | $1,236,934 | $599,389 |
| Basic Average Shares | $1,368,057 | $1,363,303 | $1,236,934 | $599,389 |
| Diluted NI Availto Com Stockholders | $-2,339,000 | $-7,038,000 | $-13,981,000 | $-15,376,000 |
| Tax Provision | $8,000 | $8,000 | $8,000 | $14,000 |
| Gain On Sale Of Ppe | $750,000 | $4,000,000 | $29,000 | $314,000 |
| Impairment Of Capital Assets | $0 | $36,000 | $113,000 | $301,000 |
| Restructuring And Mergern Acquisition | $-2,000,000 | $0 | $0 | $-70,000 |
| Gain On Sale Of Security | $2,384,000 | $-1,474,000 | $468,000 | $3,209,000 |
| Provision For Doubtful Accounts | $4,745,000 | $0 | - | - |
| Research And Development | $9,000 | $53,000 | $64,000 | $1,509,000 |
| Selling General And Administration | $7,001,000 | $9,641,000 | $8,234,000 | $15,036,000 |
| Minority Interests | - | $0 | $5,000 | $236,000 |
| Gain On Sale Of Business | - | - | $0 | $1,138,000 |
| Other Special Charges | - | - | - | - |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $4,101,000 | $6,184,000 | $12,802,000 | $20,993,000 |
| Total Assets | $6,546,000 | $13,517,000 | $19,705,000 | $28,922,000 |
| Total Non Current Assets | $190,000 | $4,275,000 | $4,733,000 | $3,524,000 |
| Other Non Current Assets | $143,000 | $92,000 | $3,832,000 | $956,000 |
| Non Current Note Receivables | $0 | $3,966,000 | $0 | - |
| Goodwill And Other Intangible Assets | $39,000 | $39,000 | $39,000 | $40,000 |
| Current Assets | $6,356,000 | $9,242,000 | $14,972,000 | $25,398,000 |
| Other Current Assets | $156,000 | $931,000 | $807,000 | $795,000 |
| Assets Held For Sale Current | $0 | $96,000 | $1,180,000 | $417,000 |
| Inventory | $1,212,000 | $904,000 | $837,000 | $2,321,000 |
| Receivables | $425,000 | $3,069,000 | $506,000 | $1,221,000 |
| Notes Receivable | $0 | $1,894,000 | $0 | - |
| Accounts Receivable | $425,000 | $1,175,000 | $506,000 | $1,221,000 |
| Allowance For Doubtful Accounts Receivable | $-134,000 | $0 | $0 | $-3,000 |
| Gross Accounts Receivable | $559,000 | $1,175,000 | $506,000 | $1,224,000 |
| Cash Cash Equivalents And Short Term Investments | $4,563,000 | $4,242,000 | $11,642,000 | $20,644,000 |
| Cash And Cash Equivalents | $259,000 | $4,242,000 | $6,518,000 | $20,644,000 |
| Other Intangible Assets | - | - | $39,000 | $40,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $0 | $155,000 | $1,007,000 | $2,017,000 |
| Long Term Debt And Capital Lease Obligation | - | $0 | $155,000 | $1,007,000 |
| Current Debt And Capital Lease Obligation | - | $155,000 | $852,000 | $1,010,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,406,000 | $7,294,000 | $7,002,000 | $8,022,000 |
| Total Non Current Liabilities Net Minority Interest | $347,000 | $4,731,000 | $3,412,000 | $3,813,000 |
| Derivative Product Liabilities | $347,000 | $2,731,000 | $1,257,000 | $806,000 |
| Current Liabilities | $2,059,000 | $2,563,000 | $3,590,000 | $4,209,000 |
| Other Current Liabilities | $270,000 | $270,000 | $770,000 | $296,000 |
| Payables And Accrued Expenses | $1,789,000 | $2,138,000 | $1,968,000 | $2,903,000 |
| Payables | $1,453,000 | $733,000 | $543,000 | $953,000 |
| Accounts Payable | $1,453,000 | $703,000 | $485,000 | $905,000 |
| Other Non Current Liabilities | - | $2,000,000 | $2,000,000 | $2,000,000 |
| Other Payable | - | - | $44,000 | $298,000 |
| Current Deferred Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $4,140,000 | $6,223,000 | $12,841,000 | $21,033,000 |
| Total Equity Gross Minority Interest | $4,140,000 | $6,223,000 | $12,703,000 | $20,900,000 |
| Stockholders Equity | $4,140,000 | $6,223,000 | $12,841,000 | $21,033,000 |
| Retained Earnings | $-281,217,000 | $-278,878,000 | $-271,840,000 | $-257,859,000 |
| Gains Losses Not Affecting Retained Earnings | - | $0 | $101,000 | $0 |
| Other Equity Adjustments | - | - | $101,000 | - |
| Other | ||||
| Ordinary Shares Number | $1,373,120 | $1,364,940 | $1,285,337 | $616,079 |
| Share Issued | $1,373,120 | $1,364,940 | $1,285,337 | $616,079 |
| Tangible Book Value | $4,101,000 | $6,184,000 | $12,802,000 | $20,993,000 |
| Invested Capital | $4,140,000 | $6,223,000 | $12,841,000 | $21,033,000 |
| Working Capital | $4,297,000 | $6,679,000 | $11,382,000 | $21,189,000 |
| Capital Lease Obligations | $0 | $155,000 | $1,007,000 | $2,017,000 |
| Total Capitalization | $4,140,000 | $6,223,000 | $12,841,000 | $21,033,000 |
| Additional Paid In Capital | $285,292,000 | $285,036,000 | $284,515,000 | $278,827,000 |
| Capital Stock | $65,000 | $65,000 | $65,000 | $65,000 |
| Common Stock | $65,000 | $65,000 | $65,000 | $65,000 |
| Current Capital Lease Obligation | $0 | $155,000 | $852,000 | $1,010,000 |
| Current Accrued Expenses | $336,000 | $1,405,000 | $1,425,000 | $1,950,000 |
| Dueto Related Parties Current | $0 | $30,000 | $58,000 | $48,000 |
| Net PPE | $8,000 | $178,000 | $862,000 | $2,528,000 |
| Accumulated Depreciation | $-1,899,000 | $-1,866,000 | $-1,942,000 | $-2,811,000 |
| Gross PPE | $1,907,000 | $2,044,000 | $2,804,000 | $5,339,000 |
| Leases | $1,584,000 | $1,584,000 | $1,590,000 | $1,590,000 |
| Machinery Furniture Equipment | $323,000 | $323,000 | $422,000 | $1,222,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $955,000 | $615,000 | - | - |
| Raw Materials | $257,000 | $289,000 | - | - |
| Other Short Term Investments | $4,304,000 | $0 | $5,124,000 | $0 |
| Minority Interest | - | $0 | $-138,000 | $-133,000 |
| Long Term Capital Lease Obligation | - | $0 | $155,000 | $1,007,000 |
| Other Properties | - | $137,000 | $792,000 | $2,527,000 |
| Treasury Shares Number | - | - | $0 | - |
| Current Deferred Revenue | - | - | - | - |
| Goodwill | - | - | - | - |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-4,739,000 | $-9,643,000 | $-15,299,000 | $-14,049,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-4,739,000 | $-9,627,000 | $-15,294,000 | $-13,977,000 |
| Cash Flow From Continuing Operating Activities | $-4,739,000 | $-9,627,000 | $-15,294,000 | $-13,977,000 |
| Operating Gains Losses | $-3,134,000 | $-2,591,000 | $-6,584,000 | $-4,661,000 |
| Investing Activities | ||||
| Investing Cash Flow | $750,000 | $7,342,000 | $-4,344,000 | $1,417,000 |
| Cash Flow From Continuing Investing Activities | $750,000 | $7,342,000 | $-4,344,000 | $1,417,000 |
| Capital Expenditure | - | $-16,000 | $-5,000 | $-72,000 |
| Financing Activities | ||||
| Financing Cash Flow | $6,000 | $9,000 | $5,512,000 | $4,519,000 |
| Cash Flow From Continuing Financing Activities | $6,000 | $9,000 | $5,512,000 | $4,519,000 |
| Issuance Of Capital Stock | - | $0 | $5,997,000 | $5,000,000 |
| Net Common Stock Issuance | - | $0 | $5,997,000 | $5,000,000 |
| Common Stock Issuance | - | $0 | $5,997,000 | $5,000,000 |
| Net Other Financing Charges | - | - | $-497,000 | $-488,000 |
| Other | ||||
| End Cash Position | $259,000 | $4,242,000 | $6,518,000 | $20,644,000 |
| Beginning Cash Position | $4,242,000 | $6,518,000 | $20,644,000 | $28,685,000 |
| Changes In Cash | $-3,983,000 | $-2,276,000 | $-14,126,000 | $-8,041,000 |
| Proceeds From Stock Option Exercised | $6,000 | $9,000 | $12,000 | $7,000 |
| Net Investment Purchase And Sale | $0 | $5,024,000 | $-5,023,000 | $0 |
| Sale Of Investment | $0 | $5,024,000 | $2,502,000 | $0 |
| Net Business Purchase And Sale | $0 | $-2,000,000 | $569,000 | $569,000 |
| Purchase Of Business | $0 | $-2,000,000 | $0 | $0 |
| Net Intangibles Purchase And Sale | $750,000 | $4,000,000 | $0 | - |
| Sale Of Intangibles | $750,000 | $4,000,000 | $0 | - |
| Net PPE Purchase And Sale | $0 | $318,000 | $110,000 | $848,000 |
| Sale Of PPE | $0 | $334,000 | $115,000 | $920,000 |
| Purchase Of PPE | $0 | $-16,000 | $-5,000 | $-72,000 |
| Change In Working Capital | $96,000 | $-596,000 | $-2,744,000 | $1,050,000 |
| Change In Other Current Liabilities | $-57,000 | $0 | $0 | $6,000 |
| Change In Other Current Assets | $-50,000 | $72,000 | $2,000 | $16,000 |
| Change In Payables And Accrued Expense | $-429,000 | $-332,000 | $-512,000 | $-773,000 |
| Change In Payable | $-429,000 | $-332,000 | $-512,000 | $-773,000 |
| Change In Account Payable | $-399,000 | $-303,000 | $-522,000 | $-757,000 |
| Change In Prepaid Assets | $775,000 | $-124,000 | $1,000 | $91,000 |
| Change In Inventory | $-308,000 | $550,000 | $-2,419,000 | $1,118,000 |
| Change In Receivables | $165,000 | $-762,000 | $184,000 | $592,000 |
| Other Non Cash Items | $372,000 | $-355,000 | $6,439,000 | $196,000 |
| Stock Based Compensation | $234,000 | $512,000 | $717,000 | $1,106,000 |
| Asset Impairment Charge | $0 | $328,000 | $577,000 | $3,465,000 |
| Depreciation Amortization Depletion | $32,000 | $113,000 | $287,000 | $479,000 |
| Depreciation And Amortization | $32,000 | $113,000 | $287,000 | $479,000 |
| Depreciation | $32,000 | $113,000 | $287,000 | $439,000 |
| Gain Loss On Investment Securities | $-2,384,000 | $1,474,000 | $-6,544,000 | $-3,209,000 |
| Gain Loss On Sale Of PPE | $-750,000 | $-4,065,000 | $-40,000 | $-314,000 |
| Net Income From Continuing Operations | $-2,339,000 | $-7,038,000 | $-13,986,000 | $-15,612,000 |
| Purchase Of Investment | - | $0 | $-7,525,000 | $0 |
| Sale Of Business | - | $0 | $569,000 | $569,000 |
| Interest Paid Supplemental Data | - | - | $0 | $1,000 |
| Changes In Account Receivables | - | - | $184,000 | $592,000 |
| Amortization Cash Flow | - | - | $0 | $40,000 |
| Amortization Of Intangibles | - | - | $0 | $40,000 |
| Gain Loss On Sale Of Business | - | - | $0 | $-1,138,000 |
| Repayment Of Debt | - | - | - | $0 |
| Income Tax Paid Supplemental Data | - | - | - | $0 |
| Effect Of Exchange Rate Changes | - | - | - | $0 |
| Net Issuance Payments Of Debt | - | - | - | $0 |
| Net Long Term Debt Issuance | - | - | - | $0 |
| Long Term Debt Payments | - | - | - | $0 |
| Issuance Of Debt | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
| Change In Other Working Capital | - | - | - | - |
| Unrealized Gain Loss On Investment Securities | - | - | - | - |
| Amortization Of Securities | - | - | - | - |
| Deferred Tax | - | - | - | - |
| Deferred Income Tax | - | - | - | - |
Fetched: 2026-06-17